Cryo Cell International (CCEL) Long-Term Deferred Tax (2016 - 2026)
Cryo Cell International's Long-Term Deferred Tax history spans 15 years, with the latest figure at $23.6 million for Q1 2026.
- Quarterly results put Long-Term Deferred Tax at $23.6 million for Q1 2026, up 13.55% from a year ago — trailing twelve months through Feb 2026 was $23.6 million (up 13.55% YoY), and the annual figure for FY2025 was $23.6 million, up 13.55%.
- Long-Term Deferred Tax for Q1 2026 was $23.6 million at Cryo Cell International, roughly flat from $23.6 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $23.6 million in Q4 2025 to a low of $12.0 million in Q1 2022.
- The 5-year median for Long-Term Deferred Tax is $20.5 million (2023), against an average of $17.8 million.
- The sharpest move saw Long-Term Deferred Tax soared 49.12% in 2023, then grew 1.51% in 2024.
- Year by year, Long-Term Deferred Tax stood at $13.7 million in 2022, then skyrocketed by 49.12% to $20.5 million in 2023, then rose by 1.51% to $20.8 million in 2024, then rose by 13.55% to $23.6 million in 2025, then changed by 0.0% to $23.6 million in 2026.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $23.6 million, $23.6 million, and $20.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.